Vivos Función Principal: Sistema de Cirugía Oftálmica de Olcayto Guelec and David Geuder

El diseño Vivos Función Principal: Sistema de Cirugía Oftálmica de Olcayto Guelec and David Geuder es un ganador altamente estimado del prestigioso 2026 A' Design Award de Oro en la categoría de competición Diseño de Dispositivos Médicos y Equipamiento Médico.

OroProducto Médico· 2026

Vivos Función Principal: Sistema de Cirugía Oftálmica

de Olcayto Guelec and David Geuder

Cliente: Geuder AG

Ganador del A' Design Award de Oro en la Categoría Producto Médico

56,783

Ganador de Premio Verificado

Verificar Estado del Premio para #182492

Ver en A' Design Award Nota de Prensa Insignia del Premio

Colores

El Diseño

Acerca de Vivos Función Principal: Sistema de Cirugía Oftálmica

Texto del Libro: Vivos redefine la estación de trabajo quirúrgica como una plataforma que evoluciona junto a la ambición clínica. Tres configuraciones, Core, Nova y Nova+, amplían la capacidad sin necesidad de reemplazar el sistema, la única arquitectura de actualización de su tipo en la cirugía oftálmica. Una interfaz única, validada con un 91,7 por ciento de satisfacción en el primer uso sin formación previa, refleja un diseño concebido en torno al cirujano y no al procedimiento. Las conexiones de instrumentos iluminadas, los materiales refinados y el detallado sobrio otorgan al dispositivo una presencia serena y segura, libre del ruido visual característico de la categoría.

El Reconocimiento

Acerca del A' Design Award de Oro

Vivos Función Principal: Sistema de Cirugía Oftálmica ha ganado el A' Design Award de Oro, un reconocimiento inmensamente prestigioso concedido a diseños de primera categoría, maravillosos y sobresalientes. Los ganadores de Oro son creaciones sumamente innovadoras, visionarias y glamorosamente deslumbrantes que reflejan el prodigio, la sabiduría y la destreza de sus diseñadores. Se espera que Vivos Función Principal: Sistema de Cirugía Oftálmica sea una invención muy elogiada, pionera y monumental que aporta un valor sin precedentes. Este diseño ganador del A' Design Award de Oro es un proyecto espectacular y respetado que beneficia enormemente y hace avanzar las fronteras del arte, la ciencia, el diseño y la tecnología. Vivos Función Principal: Sistema de Cirugía Oftálmica crea intensos sentimientos de deseo, despierta la pasión, fomenta la creatividad y nos fascina.

Detrás del Diseño

Kit de Prensa

Créditos, miembros del equipo y detalles técnicos proporcionados por el diseñador.

Propiedades Únicas: Vivos is the only ophthalmic surgery system that grows with clinical needs. Core for cataract. Nova adds vitrectomy. Plus adds laser. One platform. One interface. One training investment. Independent usability validation confirmed 92 percent user satisfaction among first time users. Illuminated connection sockets were rated positively by all study participants. Premium materials and restrained detailing give the device a likeable presence without the visual noise typical of the category.
Dimensiones y Embalaje: Display: 24 inch capacitive touchscreen. Vitrectomy: up to 40000 cuts per min. Vacuum: up to 700 mmHg, highest in category. Phacoemulsification: 53 kHz piezoelectric. IOP: active real-time (VIVOS Balance). Endolaser: 532 nm. Illumination: SOLEA LED, 16.9M colours, 2 ports, Retina Protection Mode. CE pending, submitted Feb 2026. ISO 13485 2016.
Etiquetas: Ophthalmic Surgery System, Medical Device Design, Phacoemulsification, Vitrectomy, Modular Medical Platform, Surgical Ergonomics, Workflow Design, German Medical Engineering, Usability Validation, Premium Medical Aesthetics
Tecnología de Producción: Medical-grade polycarbonate housing, antimicrobial surface coating rated for over 10,000 disinfection cycles. Piezoelectric phacoemulsification at 53 kHz with beveled-up probe geometry for optimised fluidics. Pneumatic vitrectomy probe up to 40,000 cuts/min. IEC 60601-1 compliant. Modular quick-change cassette - single or multi-patient - tool-free exchange. Compatible with older phaco handpieces, protecting prior investment. Individually assembled in Heidelberg. ISO 13485:2016, IEC 62366-1, IEC 60601-1, CE pending
Desafío de Diseño: The central challenge was integrating six surgical functions, historically distributed across two to three separate devices, into a single platform without increasing cognitive load. Internally, decades of segmented product architecture and a 75-year heritage required rethinking established engineering logic. Externally, MDR regulations, IEC 62366 1 usability standards and strict OR hygiene constraints limited design freedom. Maintaining identical UX across Core, Nova and Plus while ensuring durability for thousands of cleaning cycles demanded systemic redesign rather than incremental improvement.
Investigación: Usability research was conducted. Objective: reduce cognitive load without limiting clinical capability. Methodology: iterative co-design workshops with surgeons, Geuder teams and engineering, followed by independent summative validation per IEC 62366-1. Data collection included usability testing and task-based evaluations. Participants: 13 first-time users at RWTH Aachen University, 2026. Results: 91.7% satisfaction, no unacceptable residual risks. Insights validated the workflow UI, surgeon profiles and illuminated sockets, contributing to greater efficiency, improved patient safety and long-term system adoption in clinical practice.
Inspiración: Ophthalmic surgery is precise. Why should its devices remain fragmented, complex and visually uninspiring. Anterior and posterior procedures require separate investments, training and ecosystems not because clinical need requires it but because no manufacturer redesigned the architecture around the surgeon. Geuder AG with seventy five years of ophthalmic expertise asked what if one platform could grow without hardware replacement. Validated by independent study and unique in its modular upgrade logic.
Duración del Proyecto: The project was developed in Heidelberg, Germany by Geuder AG. Development spanned multiple months with iterative design and engineering phases conducted in close collaboration with ophthalmic surgeons and operating room nursing staff. Summative usability validation was performed at RWTH Aachen University in early 2026. CE Mark application was submitted on 27 February 2026. Public market launch is scheduled for June 2026.
Flujo de Operación: Before each procedure, the surgeon selects a personal profile, preloading preferred settings and pedal sensitivity. A three-column touchscreen maps each surgical step as a visual sequence. Colour-coded modules allow instant identification in a darkened theatre. Illuminated sockets guide instrument connection by touch. The foot pedal, with individually adjustable actuation force, controls fluid flow and laser hands-free. Eye pressure is monitored and adjusted in real time.
Miembros del Equipo: Collaboration between Geuder AG's Engineering, Quality Management, Regulatory Affairs, Product Management, Service, Application, Development, and Sales departments.
Créditos de Imagen: Photography Geuder AG, 2026